Pure Global
NCT05833191

Efficacy of Different Nerve Stimulation Methods in Individuals With Chronic Constipation

Istanbul Medipol University Hospital·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Constipation
Drug/Device/Intervention
Auricular vagus stimulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Istanbul Medipol University Hospital
Location
Istanbul,Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Apr 15, 2023
End date
Aug 15, 2023
Enrollment
50 participants
Primary outcome

Bristol Stool Scale,Pelvic Pain Impact Questionnaire,Superficial Electromyography Biofeedback,Constipation Severity Scale,Autonomic nervous system device

Summary

Constipation is the most common digestive complaint in the general population. Normal stool
 frequency ranges from at least three times a week to a maximum of two times a day.
 Constipation can be classified into three main groups as constipation with normal transit
 time, constipation with slow transit time and dyssynergic defecation disorders.

ICD-10 classifications
ConstipationIrritable bowel syndrome with predominant constipation [IBS-C]Other laxativesPoisoning: Other laxativesOther functional intestinal disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05833191
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05833191 through Pure Global AI's free database. This phase not specified trial is sponsored by Istanbul Medipol University Hospital and is currently Recruiting. The study focuses on Constipation. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.